Publication:
Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features

Simple item page
dc.contributor.authorMartin, Vittoria
dc.contributor.authorBotta, Francesca
dc.contributor.authorZanellato, Elena
dc.contributor.authorMolinari, Francesca
dc.contributor.authorCrippa, Stefano
dc.contributor.authorMazzucchelli, Luca
dc.contributor.authorFrattini, Milo
dc.date.accessioned2017-03-13T15:57:08Z
dc.date.available2017-03-13T15:57:08Z
dc.date.issued2012
dc.description.abstractAims: Triple negative breast cancer with basal like features (TN-BCBL) do not benefit from hormonal and anti-HER2 therapies. As a considerable fraction of TN-BCBLs shows EGFR deregulation, EGFR-targeted therapies have been proposed as an option. The characterization of EGFR and EGFR-downstream members may therefore provide important predictive information. Methods and results: Based on morphological and immunophenotypic features, we identified 38 TN-BCBLs that were subsequently investigated for alterations in EGFR signaling pathways. EGFR and PTEN protein levels were studied by immunohistochemistry, EGFR gene status by FISH, EGFR, H-Ras, K-Ras, N-Ras, BRAF and PIK3CA gene mutations by direct sequencing. EGFR overexpression and loss of PTEN expression characterized the majority of TN-BCBLs (76% and 74% of patients, respectively). EGFR gene copy number gain (FISH+) was identified in 51% of analyzable patients. PIK3CA gene mutations were detected in three cases (8%), whereas EGFR, H-Ras, K-Ras, N-Ras and BRAF genes showed no mutations. Overall, out of 17 patients classified as FISH+, 12 cases (70%) showed a concomitant alteration in PI3K/PTEN pathway. Conclusions: These results provide evidence that the efficacy of anti-EGFR drugs in TN-BCBL patients could be impaired by frequent alterations in the PI3K/PTEN axis, and suggest that TN-BCBLs could benefit from tailored treatments against this axis.es
dc.formatapplication/pdfes
dc.format.extent8es
dc.identifier.eisbnHistology and Histopatholy, Volume 27, number 6 (June), 2012es
dc.identifier.issn1699-5848
dc.identifier.issn0213-3911
dc.identifier.urihttp://hdl.handle.net/10201/52457
dc.languageenges
dc.publisherF. Hernandez y JuanF. Madrid. Universidad de Murcia. Departamento de Biología Celular e Histología.es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectTriple negativees
dc.subjectBreast canceres
dc.subject.otherCDU::5 - Ciencias puras y naturales::57 - Biologíaes
dc.titleMolecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like featureses
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Martin-27-785-792-2012.pdf
Size:
3.87 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.39 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Histology and histopathology Vol.27, nº 6 (2012)